NCT00018564
Completed
Phase 3
Novel Therapies for Essential Tremor
ConditionsEssential Tremor
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Essential Tremor
- Sponsor
- US Department of Veterans Affairs
- Locations
- 1
- Status
- Completed
- Last Updated
- 17 years ago
Overview
Brief Summary
This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.
Detailed Description
Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial. Tremor will be assessed with accepted rating scales and accelerometry
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Physiology, Imaging and Modeling of Essential TremorEssential TremorParkinson DiseaseDystoniaNCT03811405University of Florida12
Completed
Phase 2
A Pilot Efficacy and Safety Study of ST101 in Essential TremorEssential TremorNCT01332695Sonexa Therapeutics, Inc.25
Terminated
Not Applicable
Transcranial Stimulation for Essential TremorEssential TremorNCT03025529Beth Israel Deaconess Medical Center8
Withdrawn
Phase 2
Acamprosate and Methazolamide for Essential TremorEssential TremorNCT06312800Henry Ford Health System
Completed
Phase 2
A Safety/Efficacy Trial of Zonisamide for Essential TremorEssential TremorNCT00223743VA Greater Los Angeles Healthcare System25